Cefta SB 500mg/250mg Injection
Marketer
Medmom Pharmaceuticals LLP
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Cefta SB 500mg/250mg Injection
Cefta SB 500mg/250mg Injection, a dual-action antibiotic, combats various bacterial infections by inhibiting microbial proliferation. Administered solely by a healthcare provider, this medication requires adherence to the prescribed regimen. Complete the full course, even with symptom improvement; premature cessation may compromise efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening symptoms or allergic reactions (e.g., rash, itching, swelling, respiratory distress) immediately. Inform your physician of all current medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration will aid recovery. Your doctor may order tests to monitor treatment response.
Uses of Cefta SB 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Cefta SB 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefta SB 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Cefta SB 500mg/250mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Cefta SB 500mg/250mg Injection works:
Ceftriaxone and sulbactam, combined as Cefta SB 500mg/250mg Injection, offer a dual-action antibacterial approach. Ceftriaxone, a potent antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to survive. The addition of sulbactam, a beta-lactamase inhibitor, overcomes bacterial resistance mechanisms, thereby optimizing Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of alcohol and Cefta SB 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Cefta SB 500mg/250mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to fetuses; nonetheless, clinical data from human trials are scarce.
Breast feedingCAUTION
The administration of Cefta SB 500mg/250mg Injection to breastfeeding mothers requires careful consideration. It is recommended to discontinue breastfeeding throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Cefta SB 500mg/250mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Cefta SB 500mg/250mg Injection use in patients with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Cefta SB (500mg/250mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Medical advice is recommended. Dosage alterations for Cefta SB (500mg/250mg) injection are not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefta SB 500mg/250mg Injection :
Omit a Cefta SB 500mg/250mg Injection dose? Seek immediate medical advice.
Facts to Know About Cefta SB 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently